ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 006,57
0,87%
Dow Jones
38 739,25
0,07%
DAX
18 575,94
0,86%
Brent Oil
78,195
1,41%
Bitcoin
71 471,42
1,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) Actualités

GENE Genetic Technologies Ltd

1,8601
-0,0649 (-3,37%)
Dernière mise à jour : 18:39:27
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Genetic Technologies Ltd GENE NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0649 -3,37% 1,8601 18:39:27
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,78 1,75 1,92 1,925
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/6/202414:00GLOBEGeneType and Stayhealthy Announce Landmark Distribution..
05/6/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202414:00GLOBEGTG Launches Revolutionary geneType Test covering 100% Risk..
29/5/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202414:00GLOBEGeneType and Humanise Health host “Know Your Risk” Event
06/5/202414:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
22/4/202421:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
18/4/202418:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/4/202414:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/4/202414:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/4/202414:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/4/202414:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/4/202414:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/3/202413:00GLOBEGTG Global Collaborations and Innovation Update
25/3/202413:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
26/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202420:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202414:00GLOBELaunching our most comprehensive test and expanding into new..
09/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202414:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
28/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202323:00EDGAR2Form F-3 - Registration statement by foreign private issuers
14/12/202314:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
12/12/202314:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30/10/202313:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18/10/202314:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27/9/202315:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12/9/202314:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11/9/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202314:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202316:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30/8/202314:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09/8/202314:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28/7/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202314:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21/7/202314:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..

Dernières Valeurs Consultées

NASDAQ
GENE
Genetic Technologies
BOV
SARE11
Santander Renda DE Alugu...
LSE
81MO
Hsbc Hldg7.625s
TG
ZTOB
ZTO Express Cayman
EU
DSYAD
Dassault Systemss 0.375%...
ASX
W2VN
Way 2 Vat
AMEX
HLGE
Hartford Longevity Econo...
BIT
S32611
Societe Generale Effekten
EU
D872S
D872S
COIN
QSPUST
Quantstamp
COIN
SGGUST
SharesGram
EU
IEESG
LYXOR EESG INAV
BIT
P20LL5
NLBNPIT20LL5 20241220 280
EU
E590T
E590T
NASDAQ
AAWSOXX
Bank of Montreal Autocal...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés